Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

NCT01530711 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Hepatorenal Syndrome Type I

Interventions

DRUG: Terlipressin and albumin

Sponsor

Pere Gines